REDUCTION OF C-REACTIVE PROTEIN IS ASSOCIATED WITH REDUCED RISK OF MYOCARDIAL INFARCTION: A META-ANALYSIS OF 16 RANDOMIZED TRIALS  by Savarese, Gianluigi et al.
A250
JACC April 1, 2014
Volume 63, Issue 12
Acute Coronary Syndromes
reduCtion oF C-reaCtive protein iS aSSoCiated With reduCed riSk oF myoCardial 
inFarCtion: a meta-analySiS oF 16 randomized trialS
Poster Contributions
Hall C
Monday, March 31, 2014, 9:45 a.m.-10:30 a.m.
Session Title: Acute Coronary Syndromes: Biologic Considerations
Abstract Category: 1. Acute Coronary Syndromes: Clinical
Presentation Number: 1265-244
Authors: Gianluigi Savarese, Antonio Parente, Carmen D’Amore, Bruno Trimarco, Pasquale Perrone-Filardi, Department of Advanced Biomedical 
Sciences. Federico II University, Naples, Italy
background:  The association between C-reactive protein (CRP) levels and risk of cardiovascular (CV) events has been reported in several studies. 
However, it is unclear whether a reduction in CRP is associated with an equal reduction in risk of clinical events. Therefore we sought to investigate, 
in a meta-regression analysis of randomized studies enrolling patients treated by statins, whether changes in CRP are associated with changes in risk 
of myocardial infarction (MI) and stroke.
methods: MEDLINE, ISI Web of Science, Cochrane Database and Scopus were searched for randomized trials enrolling patients treated by statins, 
reporting CRP at baseline and at end of follow-up and CV events [MI and stroke].
results: Sixteen trials enrolling 49,407 participants were included in the analysis. Meta-analysis showed that active treatment significantly 
reduced the risk of myocardial infarction by 10.1% (RR: 0.899; 95% CI: 0.851 to 0.949; p < 0.001) and the risk of stroke by 9.6% (RR: 0.904; CI: 
0.824 to 0.992; p = 0.033). Meta-regression analysis revealed that each 10% reduction of CRP was significantly associated with 37% reduction of 
MI (Regression Coefficient (RC): 0.016; CI: 0.001 to 0.031; p = 0.036), whereas no relationship was identified between changes in CRP and risk of 
stroke (RC: 0.008; CI: -0.037 to 0.054; p = 0.703).
Conclusions: These findings demonstrate a significant correlation between the reduction of CRP and the risk of MI in high-risk patients enrolled in 
randomized clinical trials, reinforcing the concept that CRP represents a valid surrogate for coronary risk.
